Tandem Diabetes Care Inc at Bank of America Global Healthcare Conference Transcript
Good afternoon, everybody. Next up, we have Tandem Diabetes. I'm Travis Steed, the medical device analyst at BofA. We have John Sheridan, CEO; and Leigh Vosseller, CFO. So welcome, and I think John, you wanted to...
Sure. I just want to kind of give you guys a sense of the state. Thank you for having us Travis. It's always great to be here. We prefer to be on the West Coast and in at least the same time zone that we kind of are from, it's a lot easier getting up in the morning and having those early meetings.
So I guess I wanted to start off by saying that we've been pretty clear over the last quarter, couple of quarters that there's been a good deal of pressure on the business from the macroeconomic factors and from the competitive issues as well. And I would say that as we enter this year, we have seen some stabilization, which has been good.
The stabilization doesn't mean we're not experiencing pressure.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |